As of June 17, 2025, FV Pharma International Corp (FVPI) reports a ROE (Return on Equity) of -464.57%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of FV Pharma International Corp's ROE (Return on Equity)
Over recent years, FV Pharma International Corp's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2016-01-31 | -464.57% |
| 2015-01-31 | -464.57% |
| 2014-01-31 | 4.51% |
This fluctuation highlights how FV Pharma International Corp manages its efficiency in generating profits from shareholders' equity over time.
Comparing FV Pharma International Corp's ROE (Return on Equity) to Peers
To better understand FV Pharma International Corp's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| FV Pharma International Corp (FVPI) | -464.57% |
| Can B Corp (CANB) | 971.83% |
| Medican Enterprises Inc (MDCN) | 680.75% |
| Spotlight Innovation Inc (STLT) | 396.49% |
| AtheroNova Inc (AHROQ) | 312.21% |
| ITonis Inc (ITNS) | 308.44% |
Compared to its competitors, FV Pharma International Corp's ROE (Return on Equity) is among the lowest compared to peers, which may indicate less effective deployment of shareholders' capital.